Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Current Leases (2019 - 2025)

Acro Biomedical (ACBM) has 7 years of Current Leases data on record, last reported at $13651.0 in Q2 2025.

  • For Q2 2025, Current Leases fell 47.71% year-over-year to $13651.0; the TTM value through Jun 2025 reached $13651.0, down 47.71%, while the annual FY2024 figure was $26898.0, 6.17% up from the prior year.
  • Current Leases reached $13651.0 in Q2 2025 per ACBM's latest filing, down from $18009.0 in the prior quarter.
  • Across five years, Current Leases topped out at $26898.0 in Q4 2024 and bottomed at $6526.0 in Q3 2023.
  • Average Current Leases over 5 years is $20904.6, with a median of $24713.0 recorded in 2021.
  • Peak YoY movement for Current Leases: tumbled 74.37% in 2023, then skyrocketed 306.05% in 2024.
  • A 5-year view of Current Leases shows it stood at $24713.0 in 2021, then rose by 4.07% to $25719.0 in 2022, then fell by 1.49% to $25335.0 in 2023, then rose by 6.17% to $26898.0 in 2024, then plummeted by 49.25% to $13651.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $13651.0 in Q2 2025, $18009.0 in Q1 2025, and $26898.0 in Q4 2024.